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Adenovirus E1A confers enhanced cell sensitivity to
radiation and drug-induced DNA damage by a mecha-
nism involving the binding to cellular proteins. Mutant
analysis in E1A-transfected murine keratinocytes dem-
onstrates that increased sensitivity to DNA damage re-
quires at least E1A binding to the p300/CREB-binding
protein (CBP) transcriptional coactivators and to pRb
family members, indicating that this biological activity
of E1A is the result of the concomitant perturbation of
different cell pathways. Here we show that in the same
cells E1A binding to members of the retinoblastoma pro-
tein family induces transcriptional down-regulation of
the poly(ADP-ribose) polymerase (PARP) gene, coding
for a NAD-dependent enzyme stimulated by DNA breaks.
Inhibition of PARP expression is accompanied by a dec-
rement of g-irradiation-induced apoptosis, which is
overridden by reconstitution of wild type levels of
PARP. Hence, E1A effects on PARP transcription are
central determinant of the apoptotic sensitivity of E1A-
expressing keratinocytes. Conversely, E1A binding to
only p300/CBP results in an increase in PARP enzyme
activity and consequently in cell death susceptibility to
irradiation, which is effectively counteracted by the
PARP chemical inhibitor 3-aminobenzamide. Therefore,
our results identify in the E1A-mediated effects on
PARP expression and activity a key molecular event
involved in E1A-induced cell sensitization to genotoxic
stress.
Adenovirus E1A proteins stimulate entry into S-phase of the
infected cells and, in combination with E1B proteins, induce
transformation. This effect is probably the consequence of per-
turbation of a variety of cellular basal programs, like prolifer-
ation, differentiation, and programmed cell death (1). A well
characterized effect of transfected E1A alone is a marked in-
crease in cell sensitivity to DNA damaging agents (ionizing
radiation and DNA-targeted chemotherapeutic compounds
such as doxorubicin and 5-fluorouracil) in epithelial tumor (2,
3) and immortalized cells (4, 5), as well as in primary embryo
fibroblasts (6, 7). At the doses employed in the cited studies, the
morphology of cell death induced by these agents is that of
apoptosis, which under conditions of serum deprivation and
high cell density could be elicited per se by E1A transfection,
without any additional stimulus (8). Therefore, it is likely that
the basis of E1A-induced enhanced sensitivity to DNA damage
relies at least partially in the lowering of the apoptotic thresh-
old, by acting at a distal step in the programmed cell death
pathway. E1A encodes two mRNA species, named 13S and 12S,
which give respectively a 289- and a 243-amino acid protein,
identical apart from an internal stretch of 46 amino acids. E1A
proteins present two conserved regions (CR1 and CR2), which
are known from mutational studies to be responsible for the
induction of transformation and to be the site of interaction
with several identified cellular proteins (reviewed in Ref. 9).
These proteins are p107, p130, and p105Rb, belonging to the
pRb tumor suppressor gene family and which interact primar-
ily with CR2 with a weak cooperativity of CR1, and p300 and
CREB1-binding protein (CBP) of the p300/CBP family of tran-
scriptional coactivators, which require a portion of CR1 and the
N terminus for binding (10). Since these proteins have key
regulatory roles in different cell pathways, the perturbations
induced by their association with E1A are thought to be re-
sponsible for the complex biological activity of E1A (11). Nev-
ertheless, the mechanism leading to E1A-induced cell sensiti-
zation and the exact role in this process of the bound cellular
proteins are almost totally unclear.
This study was designed with the aim of finding downstream
substrates for the action of E1A that could be involved in its
sensitization to ionizing radiation-induced apoptosis. We used
an established in vitro model of spontaneously immortalized
murine keratinocytes, stably transfected with full-length E1A
13S or with E1A 13S deletion mutants unable to bind either
p300 (mutant NTdl598) or p105Rb (mutant NTdl922/947) fam-
ily members (5). In these cells, we demonstrate that E1A down-
regulates the expression of PARP (EC 2.4.2.30), an abundant
nuclear enzyme endowed with DNA damage-triggered ADP-
ribosylating activity and involved in the late apoptotic cascade
as a substrate/effector protein (12). By testing the behavior of
the two mutant E1A-expressing cell lines, we also show that
this effect is mediated by E1A binding to pRb proteins and is
accompanied by apoptosis resistance to g-rays, while E1A bind-
ing to the transcriptional integrators p300/CBP enhances
PARP activity and increases irradiation-induced cell death.
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Cells, Cell Cultures, and Treatments—Mouse Pam212 cells are a
spontaneously immortalized keratinocyte line (13), while Pam212-de-
rived transgenic cell lines carring full-length E1A, and the NTdl598 and
NTdl922/947 E1A mutants were obtained by lipofection with retroviral
constructs (MD-E1a 13S, MD-E1a NTdl598, MD-E1a NTdl992/947, re-
spectively) carrying the G418 resistance gene (14). The E1A mutants
used in this study have been previously described (15, 16). Mutant
NTdl598 (amino acids 2–13 deleted) binds only to members of the pRb
family, p105 and p107 at least, while mutant NTdl922/947 (amino acids
122–129 deleted) binds only to p300. All transgenic cell lines expressed
similar levels of E1A, as previously assessed by Western blot and
immunoprecipitation (14). All cells were grown in DMEM supple-
mented with 10% FCS (Life Technologies, Inc., Paisley, United King-
dom) 200 units/ml penicillin, 100 mg/ml streptomycin (Sigma, Milan,
Italy), 1 mg/ml G418 (Life Technologies, Inc.) for the transgenic lines,
and incubated at 37 °C in a 5% CO2 atmosphere. Cells were g-irradiated
with a 60Co source at 57-cm distance and at a dose rate of 1.55 Gy/min.
In all experiments cells were plated in 90-mm Petri dishes 24 h before
irradiation, and the time of irradiation was taken as the zero time. For
irradiation in the presence of the PARP inhibitor 3-AB, cells were
incubated with 5 mM 3-AB for 2 days, then irradiated and subjected to
time-lapse videomicroscopy scoring of cell death.
Cell Viability and Long Term Survival—Cellular viability was as-
sessed by the crystal violet method. Briefly, cells were plated in 24-well
plates (2 3 104/well), fixed at the indicated time with 1% glutaralde-
hyde for 10 min, washed twice with PBS, and stained by 1.5 ml of 0.1%
crystal violet solution for 30 min. Wells were rinsed with distilled water
until the dye was washed off and the absorbance was read at 590 nm
after taking the dye up in 10% acetic acid. The long term survival was
determined by a clonogenic survival assay as described previously (17).
Cell Extracts and Western Blotting—Cells were plated 24 h before
treatment, and the determination of the cell number was done by
classical trypsinization procedure; for protein extraction, cells were
scraped in cold PBS (pH 7.4), spun 10 min at 1000 rpm at 4 °C, and
suspended at 2 3 105 cells/ml in 1 3 sample buffer (62.5 mM Tris (pH
6.8), 6 M urea, 10% glycerol, 2% SDS, 0.003% bromphenol blue, 5%
2-mercaptoethanol). Cells were then lysed by sonication on ice for 20 s
(microtips at limit, 40% duty cycle, Sonicator Vibracell, Sonics and
Materials, Dunbury, CT) and incubated 15 min at 65 °C before loading.
Samples were electrophoresed on a SDS-polyacrylamide minigel (8%
W/v) for 1 h and 15 min at 100 V. Proteins were transferred onto
nitrocellulose membrane (Hybond C from Amersham Pharmacia Bio-
tech) at 4 °C under stirring at 100 V for 1 h. The membrane was blocked
in PBSBT (PBS 1 3 (pH 7.4), 5% BSA, 0.1% Tween 20) for 30 min,
incubated with the polyclonal anti-PARP antibody C2–10 (18), provided
by Dr. G. Poirier, at a final dilution of 1:10,000 for 2 h in blocking
solution. Bands were visualized with horseradish peroxidase-conjugated
antimouse immunoglobulin (1:2500 in blocking solution), enhanced
chemiluminescence reagent (ECL, Amersham Pharmacia Biotech),
and subsequent exposure to hyperfilm-enhanced chemiluminescence
(Amersham Pharmacia Biotech).
Activity Gel—The PARP automodification activity was detected on
the gel using the incorporation of [32P]NAD1 into [32P]poly(ADP-ribose)
as described (19). The extracts prepared from control and treated cells
were electrophoresed in a 7.5% polyacrylamide gel. Thereafter the gel
was soaked at room temperature with shaking for 30 min in renatur-
ation buffer (50 mM Tris-HCl (pH 8.0), 3 mM 2-mercaptoethanol), for 30
min in renaturation buffer containing 6 M guanidine hydrochloride, and
finally for 30 min in renaturation buffer. The enzymatic reaction was
carried out for 1 h a 37 °C in 3 ml of 100 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, 1 mM NAD, 1 mM dithiothreitol, and 5 mCi/ml [
32P]NAD (800
Ci/mmol, NEN Life Science Products). Nonincorporated NAD was re-
moved by washes with cold 10% trichloroacetic acid followed by washes
with cold 1 M HCl. The gel was dried and subjected to autoradiography
using Kodak X-Omat AR5 films. Alternatively radioactive bands were
detected and quantified with a PhosphorImager 445 SI (Molecular
Dynamics, Sunnyvale, CA).
Time-lapse Videomicroscopy–Cells were plated in 25-cm2 flasks and
incubated in a 5% CO2 atmosphere under a time-lapse videomicroscopy
apparatus (20). Briefly, randomly chosen fields of 100 cells were mon-
itored at a rate of one frame every 3 min for 72 h. Cells were considered
to undergo apoptotic cell death when exhibiting membrane blebbing,
shrinkage, and fragmentation in apoptotic bodies, followed in some
cases by membrane disruption and a morphology of secondary necrosis.
The scoring was carried out manually marking the dying cells on a
transparency attached to the time-lapse monitor. Results are expressed
as either the cumulative number of apoptotic events at the final time
point or plotted against time with scoring every 5 h. For experiments
involving transient expression of the pCDNA3-mPARP vector cells were
plated in 24-well plates, transfected as reported, and incubated in a 5%
CO2 chamber under the time-lapse apparatus.
Semiquantitative RT-PCR—For the quantification of PARP mRNA
levels in Pam212 cells, total RNA was extracted using the RNeasy Midi
kit (Quiagen, Hilden, Germany) and treated with RQ1 Rnase-free
Dnase (Promega, Madison, WI) before reverse transcription, to exclude
any possible amplification of contaminating genomic DNA. After etha-
nol precipitation RNA was dissolved in 10 ml of RNasin (1 unit/ml),
quantitated and analyzed on agarose gel. The reverse transcription
mixture (100 ml) contained 10 ml (about 10 mg) of total RNA, 100 units
of RNasin, 25 mg of BSA, 1 mM dNTPs, 12 mM random hexamers
(Genosys, The Woodlands, TX), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3
mM MgCl2, and 10% glycerol. After heating at 80 °C for 59 and rapid
cooling, 1000 units of Moloney murine leukemia virus RT (Promega)
were added, the mixture was incubated at 37 °C for 60 min, and the
reaction was stopped by heating at 95 °C for 15 min. The cDNA was
then purified by phenol-chloroform, ethanol-precipitated, and resus-
pended in water. Semiquantitative determination of PARP mRNA lev-
els was done by an internal standard-based PCR assay with serial
dilution of cDNA and using b-actin as reference gene, as described
previously (21). A 279-bp segment on the murine PARP cDNA sequence
(GenBankTM accession number X14206) was targeted with upstream
primer 59-AGGCCCTAAAGGCTCAGAAT-39, bases 791–810, and
downstream primer 59-CTAGGTTTCTGTGTCTTGAC-39, bases 1051–
1070, while a 326-bp segment of the murine b-actin sequence was
amplified with upstream primer 59-GCGGGAAATCGTGCGTGACATT-
39, bases 2106–2127, and downstream primer 59-GATGGAGTTGAAG-
GTAGTTTCGTG-39, bases 2409–2432. Fifty ml of the PCR reaction
mixture were as follows: 0–5 ml of cDNA solution, 1 mM primers, 200 mM
dNTPs, 15 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH 8.8), sterile
water to 45 ml, 2.5 units of Taq Gold polymerase (Perkin-Elmer, Nor-
walk, CT). The PCR profile was 5 min at 94 °C and then 30 min at
94 °C, 30 min at 54 °C (PARP), or at 60 °C (b-actin) and 30 min at 72 °C
for 25 cycles. Amplification products were run on a 2% agarose gel and
the ethidium bromide-stained bands quantitated by densitometric anal-
ysis. Within the linear range of amplification at least three values of
PARP amplification products were normalized to the starting cDNA
volumes and referred to the corresponding b-actin values.
Plasmid Constructs—Murine genomic DNA extracted from Pam212
cells by the DNeasy Tissue Kit (Quiagen) was PCR-amplified following
standard procedures with the primers 59-GTGGAATTATTTGGGC-
GAAC-39 (upstream, from 309 to 328 of GenBankTM accession number
D14553) and 59-AATACTCTCGCTGCATTTCT-39 (downstream, from
741 to 760), which give a 451-bp product spanning a portion of the
murine PARP 59 regulatory region highly homologous to the previously
characterized rat PARP promoter (from 2237 to 113, see Ref. 39). The
resulting amplification product was cloned in the pCRII vector, se-
quenced, digested with SacI and XhoI, and subcloned into the pCAT3-
Basic vector (Promega, Madison, WI), a CAT expression plasmid opti-
malized for the analysis of enhancer and promoter sequences, after
linearization with SacI and XhoI. The pCAT3-B-mpPARP vector was
amplified in the bacterial strain JM109. For production of the murine
PARP expressing vector an aliquot of the murine cDNA obtained from
Pam keratinocytes was PCR-amplified with the primers 59-GGGCT-
GCGGCAGCACGAGAA-39 (upstream, from 63 to 82) and 59-GACTCG-
GCTACCCCTCGCAC-39 (downstream, from 3127 to 3146) to obtain the
full PARP open reading frame (3083 bp). After cloning in pCRII and
partial sequencing for confirmation, the insert was digested with Hin-
dIII and XhoI and subcloned into pCDNA3 (Invitrogen, Carlsbad, CA)
after linearization with the same restriction enzymes to obtain the
pCDNA3-mPARP vector, in which the expression of murine PARP is
under the control of the cytomegalovirus promoter.
Transient Transfection and CAT Assay—For CAT assay in the wild
type and E1A Pam212 keratinocytes the plasmids pCAT3-B-mpPARP
and pCAT3-Control were used, the latter containing SV40 promoter
and enhancer sequences and being a standard for comparison of CAT
activities in different cell lines. Transient transfection of these CAT
reporter plasmids and of the pCDNA3-mPARP expression vector was
done by a lipofection procedure. The day before transfection, cells were
plated in 24-well plates at 8 3 104 cells/well, being 70% confluent after
24 h. For each well of cells 0.4 mg of plasmid DNA and 2 ml of Lipo-
fectAMINE 2000 Reagent (Life Technologies, Inc.) were diluted sepa-
rately in 50 ml of cell culture medium and incubated at room tempera-
ture for 10 min. The diluted DNA and cationic lipid were combined and
incubated further for 20 min. The growth medium was removed from


























cells and 0.5 ml of DMEM added, then the plasmid-lipid complexes (100
ml) were directly added to each well. Cells were incubated for 5 h, the
DMEM replaced with complete medium and further incubated for ad-
ditional 24 h. CAT activity was then monitored by liquid scintillation
counting of CAT reaction products. 48 h post-transfection cell extracts
obtained with 100 ml of xylene were incubated in a reaction mix con-
taining 3H-labeled chloramphenicol and n-butyryl coenzyme A. The
n-butyryl chloramphenicol partitions mainly into the xylene phase,
while unmodified chloramphenicol remains predominantly in the aque-
ous phase (22). The xylene phase was mixed with scintillant and
counted in a scintillation counter. The ratio of the counts obtained for
each cell line with pCAT3-B-mpPARP and pCAT3-Control, normalized
to the protein content of the sample determined by the BCA Protein
assay (Pierce), gave the level of activity of the PARP murine promoter.
For normalization of the transfection efficiency of the pCDNA3-mPARP
vector, an aliquot of the transfected cells was subjected to activity gel
determination of PARP as described previously, and only those samples
giving a PARP activity comparable with the wild type Pam212 kerati-
nocytes (80%) were subjected to the time-lapse analysis.
RESULTS
Short and Long Term Survival of Wild Type and E1A-trans-
formed Keratinocytes Exposed to g-Irradiation—We assessed
the response to 5 Gy of g-irradiation of a panel of murine
Pam212 keratinocytes stably expressing full-length (FL) and
deleted E1A 13S constructs. The effect of g-rays was evaluated
by measuring cell viability with the crystal violet method and
proliferative potential with the clonogenic survival assay. As
shown in Fig. 1A, at 72 h after 1, 3 and 5 Gy of irradiation only
the FL E1A Pam212 keratinocytes exhibited a significant de-
crease in viability with respect to the unirradiated control,
which was dose-dependent and reached 65% at 5 Gy. Wild type
Pam212 keratinocytes and Pam cells stably expressing two
E1A mutants, NTdl598 and NTdl922/944, that are incapable of
binding respectively to p300/CBP and to p105Rb family mem-
bers (16), showed no statistically significant difference with
respect to the untreated cells. Similarly, a clonogenic survival
assay carried out after 7 days from irradiation (Fig. 1B) indi-
cates that only the FL E1A-transformed keratinocytes are pro-
foundly impaired in their proliferative potential, as demon-
strated by the marked reduction in the number of cells capable
of colony formation with respect to the slight survival decrease
observed for the wild type and the mutant E1A-expressing
cells. In line with a previous characterization of this model of
stably transfected keratinocytes (5) and with other results (24),
we conclude that E1A-induced enhancement of radiosensitivity
depends on E1A binding to both p300/CBP and pRb proteins.
Effects of E1A Binding to p300 and pRb Family Members on
PARP Expression and Activity—E1A binding to its cellular
targets provokes perturbation of unknown pathways that could
be implicated in the cell sensitivity to genotoxic stress. Since
one of the determinants of cell radiosensitivity is the PARP
nuclear enzyme, we wanted to verify if the activity of this
protein could be implicated in the modulation of cell response to
g-ray by E1A, due to E1A binding to the p300/CBP transcrip-
tional coactivator, to pRb proteins, or both. Fig. 2 reports the
level of PARP activity in basal conditions and after 5 Gy of
g-irradiation (assessed by the activity gel method) and the level
of PARP expression (assessed by Western blotting and semi-
quantitative RT-PCR) for the wild type and the E1A-expressing
Pam212 keratinocytes. The binding of E1A to only pRb proteins
(NTdl598 mutant) induced a reduction of PARP enzymatic
activity paralleled by a decrease in PARP protein and mRNA
content to values under the basal physiologic values for these
cells. On the contrary, the mutant NTdl922/947, able to bind
only p300/CBP, did not affect PARP expression but induced a
marked increment of PARP activity, quantified as about three
times the basal wild type levels (data not shown). The binding
of E1A to both sets of proteins (FL E1A) resulted in a decrease
of PARP expression comparable with that induced by the
NTdl598 mutant, but the level of enzyme activity was the same
as in untransfected keratinocytes. The pattern of PARP activ-
ity in the cell panel obtained after g-irradiation was substan-
tially analogous to that of the untreated cells, showing only, as
expected, a generalized slight increment of signal attributable
to DNA damage-induced PARP overactivation, since PARP pro-
tein levels remained unchanged (not shown). Therefore, E1A
affects PARP activity differently by binding pRB proteins or
p300/CBP, the first effect being a down-regulation of PARP
expression at the mRNA and protein level and the second an
opposite action of increment of PARP activity without any
change in gene expression. The overall effect of FL E1A on
PARP appears to be the combinative result of the effects in-
duced by the two mutants, that is a down-regulation function-
ally compensated by an increased enzymatic activity.
Transcriptional Activity of the Mouse PARP Promoter in
Wild Type and E1A-transformed Keratinocytes—The down-reg-
ulation of PARP mRNA steady state levels in cells expressing
E1A proteins able to bind pRb (NTdl508 and FL E1A, Fig. 2C)
prompted us to investigate if this effect could be due to lowering
of the PARP transcriptional activity. Since the regulatory se-
quences in the rat PARP proximal promoter have been identi-
FIG. 1. Increased sensitivity to g-irradiation in E1A-express-
ing murine keratinocytes is due to E1A binding to both p300/
CBP and to pRb family members. A, at 24 h from plating, cells were
irradiated (5 Gy) at the indicated doses and viability was assessed by
crystal violet method after 72 h from irradiation, as described under
“Experimental Procedures.” Viability is expressed as percentage of un-
irradiated cells for each cell line. Symbols: white columns, wild type
Pam212 keratinocytes; dark gray columns, NTdl598: Pam 212 cells
stably expressing an E1A deletion mutant that binds only pRb family
members; light gray columns, NTdl922/947: Pam212 cells stably ex-
pressing an E1A deletion mutant which binds only p300/CBP; black
columns, FL E1A cells. Each point represents the mean 6 S.E. of four
independent experiments. B, surviving fraction was evaluated 7 days
post-irradiation at the indicated doses and is expressed as the ratio
between the number of colonies scored in the irradiated and the unir-
radiated plates. Each point represents the mean of six independent
experiments. Symbols: M, wild type; ●, NTdl598; 3, NTdl922/947; ‚,
FL E1A.


























fied (25), we cloned the mouse corresponding DNA region up-
stream to a CAT reporter plasmid, and we transiently
transfected our panel of E1A-expressing keratinocytes. CAT
activities reported in Table I demonstrate that E1A binding to
pRb (NTdl508 and FL E1A) results in a dramatic down-regu-
lation of the PARP promoter, while no significative effect is
seen after E1A binding to p300 (NTdl922/947). Taken together,
the data presented in Fig. 2 and Table I strongly suggest that
the pRb-sequestering activity of E1A is responsible for tran-
scriptional down-regulation of the PARP gene.
E1A Sensitization to g-Irradiation-induced Apoptosis in Mu-
rine Keratinocytes Is the Result of Two Contrasting Actions due
to Binding to pRb Proteins and to p300/CBP—From the data
presented in Fig. 1 we know that both sequestering activities of
cellular proteins are necessary for E1A-induced radiosensitiv-
ity in murine keratinocytes. We know that cell sensitivity to
g-rays could depend both on perturbation of the cell cycle and
on direct cell killing. Since recently PARP has been positively
implicated in the pathway of DNA damage-induced cell death,
we reasoned that the down-regulation of PARP expression ex-
erted by the pRb-sequestering activity of E1A should counter-
act the overall cytolethality of E1A. To segregate the cytolethal
from the cytostatic effect of g-rays, we used time-lapse video-
microscopy scoring of radiation-induced cumulative cell death
events in the panel of E1A-transfected cells. We counted the
number of cell deaths that occurred over a 72-h observation
interval after irradiation in a population of 100 cells. As re-
ported in Fig. 3A, the administration of 5 Gy of g-irradiation to
wild type keratinocytes produced cell death figures (presenting
invariably the morphology of apoptosis, not shown) that were
the same number of the spontaneous cell deaths observed in a
100-cell field in 72 h, about 10 apoptotic figures. This demon-
strates that the administered radiation dose, at least in the
time window of observation, is unable to change the apoptotic
threshold of Pam212 keratinocytes. The number of deaths was
instead almost tripled in the clone stably expressing full-length
E1A, indicating that E1A-induced radiosensitization is accom-
panied by a substantial decrease of the apoptotic threshold.
When we tested the cell lines expressing the two mutant E1A
constructs, we saw that the NTdl598 mutant, able to bind to
pRb proteins but not to p300/CBP, completely lost the ability of
E1A to lower the apoptotic threshold to g-rays of these cells.
Moreover, the binding of E1A to only p300/CBP (mutant
NTdl922/947) oversensitized cells to apoptosis with respect to
the wild type E1A protein. This cell death profile of the E1A
mutants is in agreement with two opposite effects exerted by
E1A on the apoptotic susceptibility of Pam212 cells, one nega-
tive due to binding to pRb and one positive due to binding to
p300/CBP. To better characterize the possible antiapoptotic
effect of E1A binding to pRb we exposed the Pam212 wild type
and NTdl598 keratinocytes to increasing doses of g-rays, ob-
taining the dose-response curve reported in Fig. 3B, which
clearly indicates, particularly at the higher radiation doses, the
antiapoptotic activity of E1A sequestering of pRb proteins.
To reconcile the increased apoptotic susceptibility with the
absence of change in radiosensitivity of the NTdl922/947 kera-
tinocytes (reported in Fig. 1 as viability and clonogenic poten-
tial), we performed a scoring of the mitotic events in this
mutant, which demonstrates a marked increment of the prolif-
eration rate.2 This increased mitotic activity could compensate
for the enhanced cell death observed and is indicative of the
complexity of effects exerted by E1A on the pathways leading to
cell proliferation and death.
PARP Expression and Activity Levels Are Determinant of
Apoptotic Sensitivity in Murine Keratinocytes Stably Express-
ing E1A Binding Mutants—The unexpected finding of the com-
bined proapoptotic-antiapoptotic activity of E1A was suggested
by the down-regulation of PARP expression in the NTdl598-
expressing keratinocytes. To directly test if this single molec-
ular event could be a determinant of apoptotic sensitivity for
the different E1A mutants, we transiently transfected the
NTdl598 keratinocytes with a pcDNA3-PARP expression vec-
tor, bearing human PARP cDNA under the control of the cyto-
megalovirus promoter. Activity gel determination of PARP
2 A. Pacini and P. Nassi, unpublished data.
FIG. 2. E1A affects PARP expression and activity differently
by binding pRb proteins or p300/CBP. Equal amounts of extracts
from each cell line were subjected to activity gel with (upper panel) and
without (lower panel) a previous exposure to 5 Gy of g-irradiation (the
g-ray-treated extracts were prepared 4 h from irradiation) (A) and to
Western blot analysis (B), to evaluate PARP activity and expression
levels. Both Western blotting and activity gel analysis were carried out
in cell extracts obtained as described under “Experimental Procedures.”
A representative experiment is reported. (C), graphic representation of
PARP mRNA levels evaluated by an internal standard-based (b-actin)
semiquantitative RT-PCR technique (see “Experimental Procedures”
for details). Amplification products were run on an agarose gel and the
ethidium bromide-stained bands were quantitated by densitometric
analysis. Each histogram represents the mean 6 S.E. of three to four
values of PARP amplification products normalized to the starting cDNA
volumes and referred to the corresponding b-actin values.
TABLE I
Down-regulation of PARP expression by E1A binding to pRb proteins
is due to transcriptional inhibition
Cells were plated at 8 3 104 cells/well in 24-well plates and after 24 h
transiently transfected (see “Experimental Procedures” for details) with
the CAT expression plasmids pCAT3-mpPARP and pCAT3-Control.
Cells were harvested, then levels of CAT activity were determined by
scintillation counting and normalized to the cell protein content. Values
are reported as mean CAT activity 6 S.D. (n 5 12) of the ratio between
the level directed by pCAT3-mpPARP and pCAT3-Control in the same
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showed that plasmid transfection reproducibly reconstituted
PARP enzymatic activity at levels comparable with those of the
wild type cells or higher (not shown). Fig. 4A reports that the
apoptotic sensitivity to 15 Gy of g-irradiation is restored after
24 h from transfection of NTdl598 Pam212 cells with the PARP
expression vector, becoming even higher than in the wild type
cells. Conversely, the administration of 3-AB, a specific inhib-
itor of PARP enzymatic activity, lowered the level of cell death
present in the NTdl922/947 mutant after 5 Gy of g-irradiation.
The dose of 5 mM of 3-AB administered 48 h before the exposure
to g-irradiation was chosen because it was able to decrease
PARP activity by 70% in wild type Pam212 cells (not shown).
As reported in Fig. 4B, 3-AB decreased the apoptotic sensitivity
of cells expressing the NTdl922/947 mutation to levels corre-
sponding to that of cells expressing the full-length E1A, dem-
onstrating that inhibition of PARP activity acts on the apop-
totic threshold of this cell model in the same manner of E1A
sequestering of pRb proteins.
DISCUSSION
Despite the substantial amount of data describing the details
of the interaction of E1A with cellular proteins, limited infor-
mation is available on how this interaction brings to the pleio-
tropic effects of E1A, including cell sensitization to genotoxic
agents. Since these agents are known to elicit a complex path-
way starting with the change in activity of DNA damage sensor
proteins (26), an obvious hypothesis is that E1A could directly
or indirectly affect the expression and activity of these proteins
to produce its profound perturbations in the downstream sig-
nals. A first confirmation of this assumption has come with the
recent demonstration that p300/CBP coactivators are essential
for the transactivation function of the p53 oncosuppressor pro-
tein (27) and that E1A sequestration of p300/CBP disrupts
functions mediated by p53 (28, 29). Since p53 is known to be
activated by its direct association with DNA strand breaks (30,
31), we wanted to study the effects of E1A on another well
known DNA lesion-scanning protein, the PARP enzyme.
Similarly to p53, PARP is activated by binding to breaks in
DNA, binding that triggers its enzymatic domain to consume
NAD for the synthesis of chains of poly(ADP-ribose) on target
proteins, including PARP itself (32). We focused on an estab-
lished model of spontaneously immortalized and stably E1A-
transfected cells, the murine Pam212 keratinocytes, to look for
a role of PARP in modulation by E1A of the response to g-ir-
radiation. We found that full-length E1A induced a clear down-
regulation of expression of PARP both at the protein and the
mRNA level and that this effect is due to transcriptional re-
pression of the PARP promoter. Moreover, mutant analysis
clearly indicated that this E1A activity is dependent on its
association with pRb-related proteins. A well described mech-
anism of in vivo stimulation of transcription by pRb is that
mediated by binding to the transcriptional activator Sp1 (33–
37). Since in the rat PARP promoter five consensus sites for
Sp1 are present to whom Sp1 has been demonstrated to bind
strongly stimulating transcription in reporter assays (38–40),
the pRb-Sp1 activator complex could be responsible for positive
regulation of the PARP promoter, destroyed by E1A-induced
sequestration of pRb. This activity of E1A is also associated
with a reduction of apoptosis elicited by g-ray, and the role of
PARP down-regulation in this process, among the other events
induced by E1A binding to pRb proteins, is sustained by the
fact that PARP expression in the same mutant cell line under
the control of a viral promoter restores cell sensitivity to g-ray.
An antiapoptotic activity of E1A mediated by PARP down-
regulation is in agreement with the demonstration of profound
protection from experimental cerebral ischemic injury in PARP
null mice (41) and with the partial protection exerted in wild
type mice by PARP chemical inhibitors (42). Cerebral ischemia
FIG. 4. Apoptotic sensitivity in cells expressing E1A mutants
correlates with PARP expression and activity. A, NTdl598 kera-
tinocytes were transiently transfected with a pcDNA3-PARP expression
vector as reported under “Experimental Procedures.” Cells were plated
in 24-well plates at 8 3 104 cells per well, transfected, and after 24 h
checked for PARP enzymatic activity. Those samples that gave an
activity comparable with that of wild type Pam212 cells were further
processed. Cells were g-irradiated (15 Gy) 24 h after transfection, then
they were analized by time-lapse videomicroscopy for 72 h as described.
Each point represents the mean 6 S.E. of six independent transfection
and irradiation experiments. Symbol: gray column, untransfected
NTdl598 cells; hatched column, transfected NTdl598 cells; white col-
umn, wild type Pam212 cells. B, 48 h before irradiation, NTdl922/947
cells were plated in 25-cm2 flasks and treated with 5 mM 3-AB. After
administration of 5 Gy of g-irradiation cells underwent to time-lapse
videomicroscopy as described. Each point is the mean 6 S.E. of four
independent experiments. Symbols: gray column, NTdl922/947 cells;
hatched column, NTdl922/947 cells 1 3-AB; black column, FL E1A.
FIG. 3. E1A binding to pRb proteins counteracts sensitization
to radiation-induced apoptosis due to E1A binding to p300/CBP.
A, cell lines were plated in 25 cm2 flasks (3 3 105 cells/flask) and after
24 h exposed or not to 5 Gy of g-irradiation, then a field of 100 cells was
monitored by time-lapse videomicroscopy for the subsequent 72 h. Dur-
ing the time-lapse recording, cells were maintained at 37 °C in a 5%
CO2 atmosphere. The cell death scoring was as described under “Ex-
perimental Procedures.” The cumulative number of cells at the time end
point is reported as mean 6 S.E. of four independent experiments.
Symbols: hatched column, unirradiated wild type Pam212 cells; white
column, wild type Pam212 cells; dark gray column, NTdl598 cells; light
gray column, NTdl922/947 cells; black column, FL E1A cells. B, time-
lapse dose-response curve of cumulative cell death events obtained after
exposure of wild type and NTd1598-expressing keratinocytes to increas-
ing doses (from 5 to 20 Gy) of g-rays. Symbols: white columns, wild type
Pam212 cells; gray columns, NTd1598 cells.


























is supposed to elicit a pathway starting with the excessive
release of glutamate by overexcited neurons and resulting in
the production of DNA damaging species (43), which in turn
overactivate PARP with the consequent depletion of NAD and
a sudden ATP fall induced by the cell effort to resynthesize
NAD, ultimately responsible for death (23).
Besides our demonstration of the role of PARP activity in
E1A cell sensitization to radiation-induced apoptosis, the com-
plex effects of E1A on the expression and activation of PARP
could represent a future tool for dissecting the regulation of
this gene, as happened in the past for other nuclear proteins
directly or indirectly affected by E1A.
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